XPO Logistics Wins Contract

XPO Logistics Wins Contract

XPO Logistics, a provider of transport and logistics solutions, said pre-market Monday it obtained a contract from BrewDog, a U.K. food and drinks company. XPO will provide class-leading temperature-controlled warehousing for BrewDog`s stockholding of craft beer at a multi-user, 125,000 square foot facility in Mossend, Scotland. The value of the contract was not disclosed. The Aberdeen-based brewery has grown from a two-man team in 2007 to over 600 employees and […]

Read More ˃
Total Signs Contract

Total Signs Contract

Total S.A and the National Iranian Oil Company (NIOC) signed a 20-year contract on Monday for the development and production of phase 11 of South Pars (SP11), the world’s largest gas field. The project will have a production capacity of 2 billion cubic feet per day or 400,000 barrels of oil equivalent per day including condensate. The produced gas will supply the Iranian domestic market starting in 2021. Total is […]

Read More ˃
Merck & Company Says Study Meets Primary Endpoint

Merck & Company Says Study Meets Primary Endpoint

Merck’s said its study of anacetrapib met its primary endpoint, significantly reducing major coronary events compared with placebo. The company has not decided whether it will file the product, anacetrapib has been viewed as effectively a call option for the story, and as a result JPMorgan said the news is an “incremental positive” for Merck. While CETPs, which lowered LDL and raise HDL, target a large potential market, the data […]

Read More ˃
Concordia International Hires Perella Weinberg Partners

Concordia International Hires Perella Weinberg Partners

Concordia International an international specialty pharmaceutical company focused on generic and legacy pharmaceutical products, said Wednesday it has engaged Perella Weinberg Partners LP to provide financial advisory services to help with the development of its long-term growth strategy. Parella Weinberg Partners’ services “may include, but are not limited to, helping the company explore and evaluate potential transactional alternatives, including initiatives to optimize its capital structure,” the company said in a […]

Read More ˃
Sorrento Therapeutics Higher

Sorrento Therapeutics Higher

Sorrento Therapeutics rose more than 12% after the company said its lead investigational product, ZTlido has demonstrated superior adhesion versus the EU reference product Versatis during a recently completed comparative adhesion performance study. These data complement a previous clinical adhesion study performed to support the new drug application (NDA) submission for ZTlido in the US, where greater than 90% of the subjects demonstrated greater than 90% adhesion over the 12-hour […]

Read More ˃